Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Alopecia is a key indicator of thallium poisoning.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Male pattern baldness involves smaller hair follicles, larger oil glands, and other tissue changes, but not major blood supply issues.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

FFA's causes may include environmental triggers and genetic factors.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

More research is needed to understand alopecia areata severity.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Both mouse and rat models are effective for testing alopecia areata treatments.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

A boy with alopecia regrew hair using a vitamin D cream after other treatments failed.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

People with chronic Alopecia Areata often have lower vitamin D levels.

Perifollicular erythema can indicate active frontal fibrosing alopecia.

Hair loss from mood stabilizers is common but can be managed without stopping the medication.